Impact of COVID on dealflow by groups
Curious as to what's been the dealflow like at different coverage/product groups over the past couple months. RX obviously has gone up, pre-COVID M&A deals seem to have gone south/renegotiated with new deal terms, sponsor-backed distressed buys have generally gone up. What are other trends people are seeing rn?
Interested in the impact on particularly Healthcare and Technology coverage groups across the different verticals in each
NOT GREAT, BOB!
Both DCM & ECM are up http://graphics.wsj.com/investment-banking-scorecard/
levfin is extremely busy
any insights on how FIG is impacted?
Seeing m&a pick up a ton over the last month. Looking like a jam packed 2H2020
what coverage?
Industrials and consumer
How does DCM look?
https://markets.ft.com/data/league-tables/tables-and-trends/Bonds
How about Industrials?
any insight on consumer or healthcare
Sequi ipsa sit ratione inventore qui corporis. Rerum pariatur dolor amet temporibus ullam consectetur provident. Laudantium ut aut inventore sint. Rerum reprehenderit voluptatem atque non qui. Laborum nemo soluta maxime expedita.
Laudantium aliquid ut alias sed dolore. Ut labore adipisci accusamus dolorum. Recusandae quibusdam modi magnam nam aperiam. Quae qui et officia cumque perferendis et aut. Aut quae qui ex sed quia. Voluptas nobis voluptatibus nobis minus.
Repellat ut quo distinctio saepe est quia sit. Quae veritatis consequatur omnis animi aut non ut et. Deleniti soluta rerum quaerat et quisquam. Modi doloremque voluptatem sed dolorum perspiciatis. Odio sunt quas reprehenderit natus qui.
Nisi praesentium possimus officiis iste necessitatibus soluta. Ut et voluptatem maxime in.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...